Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | LPL | P06858 | 2/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20619308 | 0.91 | FFAR1 (0.49) | FFAR1LPLLIPG | |
| SCHEMBL20619307 | 0.91 | FFAR1 (0.49) | FFAR1LPLLIPG | |
| SCHEMBL1559915 | 0.86 | FFAR1 (0.57) | FFAR1LPLLIPG | |
| SCHEMBL24092599 | 0.85 | FFAR1 (0.51) | FFAR1LPLLIPG | |
| SCHEMBL19005182 | 0.84 | FFAR1 (0.52) | FFAR1LPLLIPG | |
| SCHEMBL16968061 | 0.83 | FFAR1 (0.55) | FFAR1LPLLIPG | |
| SCHEMBL2515840 | 0.83 | FFAR1 (0.55) | FFAR1LPLLIPG | |
| SCHEMBL2997065 | 0.83 | FFAR1 (0.55) | FFAR1LPLLIPG | |
| SCHEMBL28507860 | 0.82 | FFAR1 (0.53) | FFAR1LPLLIPG | |
| SCHEMBL14858165 | 0.82 | FFAR1 (0.53) | FFAR1LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108546-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-23 | — | — | US | disclosed |
| WO-2025264700-A1 | GIP RECEPTOR AGONIST COMPOUNDS | ELI LILLY AND COMPANY (US) | 2025-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108546-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GCGR | FFAR1 65/4885LPL 642/4885LIPG 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.